Koenig Sheldon L.
Insider CIK 1766524 · PTLA EVP, Chief Commercial Officer · ESPR President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ESPR Esperion Therapeutics, Inc | D To issuer deriv | 2026-07-13 | 2026-07-13 | 753,000 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | D To issuer deriv | 2026-07-13 | 2026-07-13 | 647,460 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | D To issuer deriv | 2026-07-13 | 2026-07-13 | 642,000 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | D To issuer | 2026-07-13 | 2026-07-13 | 2,121,094 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2026-06-17 | 2026-06-18 | 53,588 | $3.16 | $169.3K | 2,119,111 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2026-03-17 | 2026-03-18 | 25,578 | $2.72 | $69.6K | 2,172,699 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2026-03-13 | 2026-03-16 | 647,460 | — | $0 | 647,460 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2026-03-13 | 2026-03-16 | 723,760 | — | $0 | 2,198,277 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2025-12-17 | 2025-12-18 | 48,244 | $3.67 | $177.1K | 1,470,587 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2025-09-17 | 2025-09-18 | 28,427 | $2.79 | $79.3K | 1,518,831 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2025-06-17 | 2025-06-18 | 30,474 | $1.11 | $33.8K | 1,541,488 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2025-03-18 | 2025-03-19 | 13,047 | $1.50 | $19.6K | 1,571,962 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2025-03-14 | 2025-03-17 | 753,000 | — | $0 | 753,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2025-03-14 | 2025-03-17 | 840,000 | — | $0 | 1,585,009 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2024-12-17 | 2024-12-18 | 12,447 | $2.47 | $30.7K | 739,819 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2024-09-17 | 2024-09-18 | 14,550 | $1.80 | $26.2K | 752,266 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2024-03-14 | 2024-03-15 | 642,000 | — | $0 | 642,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2024-03-14 | 2024-03-15 | 454,000 | — | $0 | 766,816 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2023-05-09 | 2023-05-10 | 20,000 | $1.26 | $25.2K | 312,816 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2023-03-17 | 2023-03-20 | 6,999 | $1.78 | $12.5K | 292,816 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2023-03-14 | 2023-03-15 | 445,000 | — | $0 | 445,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2023-03-14 | 2023-03-15 | 105,000 | — | $0 | 299,815 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2023-03-07 | 2023-03-08 | 5,441 | $5.06 | $27.5K | 194,815 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2022-09-19 | 2022-09-20 | 3,394 | $6.94 | $23.6K | 198,257 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2022-08-05 | 2022-08-08 | 8,606 | $5.80 | $49.9K | 198,771 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2022-06-17 | 2022-06-21 | 4,552 | $4.99 | $22.7K | 190,165 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2022-06-07 | 2022-06-09 | 91,000 | — | $0 | 91,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2022-03-17 | 2022-03-18 | 571 | $4.58 | $2.6K | 194,717 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2022-03-14 | 2022-03-16 | 116,000 | — | $0 | 195,288 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2021-10-29 | 2021-11-01 | 26,700 | — | $0 | 76,700 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2021-05-17 | 2021-05-18 | 120,000 | — | $0 | 120,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2021-05-17 | 2021-05-18 | 20,000 | — | $0 | 50,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2021-01-28 | 2021-01-29 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2021-01-28 | 2021-01-29 | 30,000 | — | $0 | 30,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 32,916 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 125,000 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 48,750 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 24,375 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 65,000 | $5.21 | $338.6K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 32,500 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer | 2020-07-02 | 2020-07-02 | 5,075 | $18.00 | $91.3K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer | 2020-07-02 | 2020-07-02 | 488 | $18.00 | $8.8K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2020-06-18 | 2020-07-02 | 488 | $8.36 | $4.1K | 488 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | F Tax w/h | 2020-03-02 | 2020-03-03 | 4,327 | $9.68 | $41.9K | 37,991 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2020-02-24 | 2020-02-26 | 73,125 | — | $0 | 73,125 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2020-01-31 | 2020-02-04 | 65,000 | — | $0 | 65,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2020-01-31 | 2020-02-04 | 16,250 | — | $0 | 41,523 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2019-01-31 | 2019-02-04 | 125,000 | — | $0 | 125,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2019-01-31 | 2019-02-04 | 25,000 | — | $0 | 25,000 | SEC↗ |